Inventiva Quote - IVA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.80

Bid

2.80

Offer

2.82

Volume

90,967

2.66 Day's Range 2.88

1.434 52 Week Range 4.30

Market Cap

589.878M

Previous Close

2.58

Open

2.66

Last Trade

100

2.8

Last Trade Time

21:53:15

Financial Volume

VWAP

Average Volume (3m)

24,418

Shares Outstanding

210,670,845

Dividend Yield

PE Ratio

-5.25

Earnings Per Share (EPS)

-0.52

Revenue

23.16M

Net Profit

-110.43M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.inventivapharma.com

Headquarters

Daix, Fra

Founded

Inventiva is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IVA. The last closing price for Inventiva was 2.58 €. Over the last year, Inventiva shares have traded in a share price range of 1.434 € to 4.30 €.

Inventiva currently has 210,670,845 shares in issue. The market capitalisation of Inventiva is 543.53 € million. Inventiva has a price to earnings ratio (PE ratio) of -5.25.

Inventiva et Hepalys Pharma, Inc. annoncent le lancement du programme de développement clinique de lanifibranor au Japon avec l'inclusion du premier participant dans l'étude de Phase 1

Inventiva et Hepalys Pharma, Inc. annoncent le lancement du programme de développement clinique de lanifibranor au Japon avec l'inclusion du...

Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial

Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the...

Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial

Initiation of the clinical development program of lanifibranor in Japan with the dosing of the first...

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update Revenues of €9.2 million for the full year of...

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update

Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31...

Inventiva publie ses résultats financiers préliminaires pour l'exercice fiscal 2024¹ et fait le point sur son activité

Inventiva publie ses résultats financiers préliminaires pour l'exercice fiscal 2024¹ et fait le point sur son activité Chiffre d'affaires de...

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in...

Inventiva annonce la publication dans la revue « Journal of Hepatology » des résultats de l’étude clinique de preuve de concept initiée par un investigateur évaluant lanifibranor chez des patients atteints de DT2 et MASLD

Inventiva annonce la publication dans la revue « Journal of Hepatology » des résultats de l’étude clinique de preuve de concept initiée par un...

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology

As previously reported1, the study met the primary efficacy endpoint for the treatment with lanifibranor 800mg...

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Daix (France), New York City (New York, United States), January 24, 2025 – Inventiva (Euronext Paris and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.54	23.8938053097	2.26	2.88	2.25	39902	2.51620795	DE
4	0.465	19.9143468951	2.335	2.88	2.155	26837	2.35945093	DE
12	0.27	10.6719367589	2.53	2.88	2	24418	2.33043701	DE
26	0.51	22.2707423581	2.29	3.2	1.434	38980	2.3025156	DE
52	-0.13	-4.43686006826	2.93	4.3	1.434	42954	2.7284116	DE
156	-7.4	-72.5490196078	10.2	11.5	1.434	54037	3.64932773	DE
260	-1.03	-26.8929503916	3.83	16.3	1.434	62551	7.1128505	DE

IVA - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?

The current share price of Inventiva is 2.80 €

How many Inventiva shares are in issue?

Inventiva has 210,670,845 shares in issue

What is the market cap of Inventiva?

The market capitalisation of Inventiva is EUR 543.53M

What is the 1 year trading range for Inventiva share price?

Inventiva has traded in the range of 1.434 € to 4.30 € during the past year

What is the PE ratio of Inventiva?

The price to earnings ratio of Inventiva is -5.25

What is the cash to sales ratio of Inventiva?

The cash to sales ratio of Inventiva is 25.02

What is the reporting currency for Inventiva?

Inventiva reports financial results in EUR

What is the latest annual turnover for Inventiva?

The latest annual turnover of Inventiva is EUR 23.16M

What is the latest annual profit for Inventiva?

The latest annual profit of Inventiva is EUR -110.43M

What is the registered address of Inventiva?

The registered address for Inventiva is 50 RUE DE DIJON, DAIX, 21121

What is the Inventiva website address?

The website address for Inventiva is www.inventivapharma.com

Which industry sector does Inventiva operate in?

Inventiva operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DMSBSDiagnostic Medical Systems	0.008 € (60.00%)	20k
TKWYJust Eat Takeaway.com N.V.	19.07 € (53.48%)	11.88M
ALARFAdeunis	0.846 € (30.96%)	52
ALIMRImmersion	1.87 € (27.21%)	88
MLTROTroc de l Ile	3.14 € (20.77%)	21
LUDSLucibel DS	0.0008 € (-80.00%)	69.05k
MLAATAzorean Tech	0.15 € (-37.50%)	8.31k
MLCOUCourbet	1.10 € (-15.38%)	10k
BIOSBiosenic	0.0038 € (-13.64%)	9.74M
MLCMGCMG Clean Tech	1.00 € (-9.09%)	100
ATOAtos SE	0.0031 € (-3.13%)	882.46M
ALCYBCybergun	0.0001 € (0.00%)	38.1M
BCPBanco Comercial Portugues SA	0.5616 € (2.15%)	36.44M
ALSRSSirius Media	0.0172 € (8.86%)	26.69M
ALVERVergnet	0.0005 € (0.00%)	13.94M